Association between arthritis and cardiovascular risk factors
BMC Cardiovascular Disorders | May 25, 2022
The "shelf life" of biologics for patients with psoriasis and PsA
JAMA Dermatology | May 20, 2022
Elevation of α-1,3 fucosylation contributes to osteoarthritic cartilage destruction and apoptosis
Arthritis Research & Therapy | May 19, 2022
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA)
The Lancet: Gastroenterology & Hepatology | May 05, 2022
Intensive versus standard drug therapy for symptomatic Crohn's disease strictures (STRIDENT)
The Lancet: Gastroenterology & Hepatology | May 03, 2022
Increased risk of COVID-19 in patients with rheumatoid arthritis
Arthritis Care & Research | Apr 30, 2022
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST)
The Lancet: Gastroenterology & Hepatology | Apr 30, 2022
Association of polygenic risk scores with radiographic progression in patients with rheumatoid arthritis
Arthritis & Rheumatology | Apr 29, 2022
AJM300 (carotegrast methyl), an oral alpha4-integrin antagonist, for patients with moderate ulcerative colitis: a phase 3 trial
The Lancet: Gastroenterology & Hepatology | Apr 27, 2022